Logo image of NTR

NUTRIEN LTD (NTR) Stock Analyst Ratings

NYSE:NTR - New York Stock Exchange, Inc. - CA67077M1086 - Common Stock

51.62  +0.12 (+0.23%)

After market: 51.62 0 (0%)

Buy % Consensus

74

ChartMill assigns a Buy % Consensus number of 74% to NTR. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 40. This target is -22.52% below the current price.
NTR was analyzed by 25 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about NTR.
In the previous month the buy percentage consensus was at a similar level.
NTR was analyzed by 25 analysts, which is quite many. So the average rating should be quite meaningful.
NTR Historical Analyst RatingsNTR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -83 -75 -67 -59 -51 -43 -35 -27 -19 -11 -3 5 10 15 20 25

Price Target & Forecast

Price Low Median Mean High 51.6228.0941.8540.0051.11 - -45.58% -18.93% -22.52% -0.99%
NTR Current Analyst RatingNTR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10
Up and Down Grades
Date Firm Action Rating
2025-01-13 JP Morgan Upgrade Underweight -> Neutral
2025-01-13 Piper Sandler Upgrade Underweight -> Overweight
2024-12-12 Oppenheimer Initiate Outperform
2024-12-03 Raymond James Upgrade Market Perform -> Outperform
2024-10-10 UBS Downgrade Buy -> Neutral
2024-09-24 Wells Fargo Downgrade Overweight -> Equal-Weight
2024-09-20 RBC Capital Reiterate Outperform -> Outperform
2024-09-10 Goldman Sachs Downgrade Buy -> Neutral
2024-08-16 Barclays Maintains Overweight -> Overweight
2024-08-12 ScotiaBank Maintains Sector Outperform -> Sector Outperform
2024-08-12 RBC Capital Reiterate Outperform -> Outperform
2024-08-09 BMO Capital Maintains Outperform -> Outperform
2024-08-08 Mizuho Maintains Neutral -> Neutral
2024-07-16 Wells Fargo Maintains Overweight -> Overweight
2024-07-15 RBC Capital Maintains Outperform -> Outperform
2024-07-09 UBS Maintains Buy -> Buy
2024-06-11 Piper Sandler Maintains Underweight -> Underweight
2024-05-17 Mizuho Maintains Underweight -> Underweight
2024-05-17 Piper Sandler Maintains Underweight -> Underweight
2024-05-10 Wells Fargo Maintains Overweight -> Overweight
2024-05-09 Mizuho Maintains Neutral -> Neutral
2024-04-29 Berenberg Upgrade Hold -> Buy
2024-03-26 Jefferies Initiate Buy
2024-03-01 Wolfe Research Initiate Outperform
2024-02-29 Piper Sandler Downgrade Neutral -> Underweight
2024-02-26 Wells Fargo Maintains Overweight -> Overweight
2024-02-23 RBC Capital Maintains Outperform -> Outperform
2024-02-23 JP Morgan Downgrade Neutral -> Underweight
2024-02-01 Goldman Sachs Maintains Buy -> Buy
2024-01-19 Stifel Maintains Buy -> Buy